Table 4.
Analysis of variance “ANOVA” and low significant differences “LSD” between the effects of sub-acute pretreatment of camel milk (CM) or sub-acute dose (0.5 mg/kg) or acute dose (2.5 mg/kg) of cisplatin and the pre- and simultaneous treatments of CM and sub-acute dose on the mitotic index in bone marrow cells of male mice.
Treatments (dose mg/kg) | Control group | ANOVA |
LSD |
|||
---|---|---|---|---|---|---|
F | Groups | Treatment of dose | Mean difference | Sig | ||
Sub-acute treatment (0.5 mg/kg) | I | 36.49⁎⁎⁎ | II | CM | 2.90 | |
III | Cis-DDP (0.5 mg/kg) | 33.60 | ⁎⁎⁎ | |||
IV | CM → Cis-DDP | 11.60 | ⁎⁎ | |||
V | CM + Cis-DDP | 16.90 | ⁎⁎⁎ | |||
Acute treatment (2.5 mg/kg) | I | 69.42⁎⁎⁎ | II | CM | 2.90 | |
VI | Cis-DDP (2.5 mg/kg) | 37.80 | ⁎⁎⁎ | |||
VII | CM + Cis-DDP | 20.10 | ⁎⁎⁎ |
∗p < 0.05.
p < 0.01.
p < 0.001.